Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug symbols : Hoth save search
Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery
Published: 2023-10-05 (Crawled : 14:30) - biospace.com/
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 2.9%
H: 16.2%
C: -2.11%
drug initiative therapeutics
Hoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer Patients
Published: 2023-09-11 (Crawled : 14:00) - prnewswire.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -0.81%
H: 16.39%
C: 11.07%
fda drug cancer treatment therapeutics submission
Hoth Therapeutics Announces Submission of Investigational New Drug Application for HT-001
Published: 2022-12-01 (Crawled : 18:00) - biospace.com/
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 0.49%
H: 9.58%
C: -1.72%
ht-001 drug application therapeutics submission
Hoth Therapeutics Announces it Has Successfully Completed Manufacturing Feasibility of the HT-KIT Drug Substance
Published: 2022-03-22 (Crawled : 14:00) - prnewswire.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -0.38%
H: 18.7%
C: 6.1%
drug therapeutics
Hoth Therapeutics Announces Orphan Drug Designation Granted to Cancer Therapeutic HT-KIT to Treat Mastocytosis
Published: 2022-03-11 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -6.73%
H: 0.0%
C: 0.0%
drug granted therapeutics drug designation orphan drug cancer grant designation
Hoth Therapeutics Announces the selection of NUVISAN for Manufacturing HT-001 Drug Batches for CLEER-001 Clinical Study for Cancer Patients
Published: 2022-02-09 (Crawled : 15:30) - prnewswire.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 1.93%
H: 9.89%
C: 2.64%
ht-001 drug therapeutics cancer
Hoth Therapeutics Announces Submission of Orphan Drug Designation Request for HT-KIT to Treat Mastocytosis
Published: 2021-12-21 (Crawled : 13:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: -2.64%
drug therapeutics orphan drug submission designation
Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic
Published: 2021-11-08 (Crawled : 13:15) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -0.91%
H: 3.67%
C: 1.83%
cancer contract drug
Hoth Therapeutics' HT-003 Shows Anti-inflammatory Benefits, Hoth to Expand Drug Development to Include Treatment of Inflammatory Bowel Diseases (IBDs)
Published: 2021-02-18 (Crawled : 19:00) - biospace.com/
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 0.99%
H: 14.01%
C: -13.03%
disease treatment drug
FDA Grants Hoth Therapeutics Pre-IND Meeting Regarding Proposed Drug Development Plan for HT-001 Treatment for Cancer Patients
Published: 2021-01-13 (Crawled : 15:00) - biospace.com/
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 5.8%
H: 1.69%
C: -8.02%
cancer fda drug treatment granted grant
Hoth Therapeutics Submits Request for a Pre-Investigational New Drug (Pre-IND) Meeting for HT-001, Treatment for Cancer Patients
Published: 2020-12-23 (Crawled : 16:00) - biospace.com/
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -0.6%
H: 13.94%
C: 0.0%
drug cancer treatment new drug
Endocannabinoid Pathway Targeted Drug Demonstrates Proof-of-Concept Efficacy in a Cutaneous Lupus Erythematosus Mouse Model
Published: 2020-12-21 (Crawled : 15:00) - biospace.com/
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: -1.76%
drug endocannabinoid lupus
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.